Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin sensitivity in type 2 diabetes by glycaemic control and dose escalation
NL-OMON26330Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of aspirin in cardiac morbidity (2 cohorts), sponsored by Amsterdam University Medical Center. Primary endpoint: Prevalence of laboratory-measured aspirin resistance stratified by level of glycaemic control. Planned start May 2008; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on NL-OMON26330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26330.